RNTX · Rein Therapeutics, Inc.
AI read · Neutral
The AI's read
The key limit is that the trial remains blinded, so the patient changes cannot be tied to LTI-03. Safety findings are reassuring so far, but treatment-specific safety is still being tracked. Full results are expected in 2027.